Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock par value $0.012 per share
-
Shares outstanding
-
41,009,592
-
Total 13F shares
-
1,235,726
-
Share change
-
-222,824
-
Total reported value
-
$64,175,840
-
Put/Call ratio
-
31%
-
Price per share
-
$10.16
-
Number of holders
-
43
-
Value change
-
+$52,410,474
-
Number of buys
-
28
-
Number of sells
-
11
Institutional Holders of ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) as of Q1 2021
As of 31 Mar 2021,
ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) was held by
43 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,235,726 shares.
The largest 10 holders included
MORGAN JESS S & CO INC, MILLENNIUM MANAGEMENT LLC, BlackRock Inc., Frontier Wealth Management LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Steward Partners Investment Advisory, LLC, ExodusPoint Capital Management, LP, OPPENHEIMER & CO INC, COMMONWEALTH EQUITY SERVICES, LLC, and HighTower Advisors, LLC.
This page lists
43
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.